共 50 条
- [31] Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes Results from the MERLIN-TIMI 36 Randomized Trial CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02): : 107 - 115
- [32] Prognostic performance of multiple biomarkers in patients with non-ST-Segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non_ST-Elevation Acute Coronary Syndromes- Thrombolysis In Myocardial Infarction 36) (vol 63, pg 1644, 2014) JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (23) : 2642 - 2642
- [36] The role of B-type natriuretic peptide testing in patients with acute coronary syndromes MINERVA CARDIOANGIOLOGICA, 2012, 60 (02): : 175 - 182
- [37] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14): : 1014 - 1021